- 18 October 2006 -

Millipore opens US$50 Million R&D centre

Millipore has opened a US$50 million research and development centre in Massachusetts, USA , which it intends to use in the development of its technologies and extension of its applications knowledge, allowing it to meet the growing demands of the global biopharmaceutical market and the life sciences industry.

The centre will make it possible for Millipore to develop full-scale applications performance data and processes that simulate commercial conditions to help pharmaceutical and biotechnology companies optimise their manufacturing productivity, ensure the quality of drugs, and scale up the production of difficult-to-manufacture biologics, Millipore says.

"Our new Bioprocess R&D Center is a demonstration of our [.]continuing investment in technologies and facilities that will help us to deliver innovative, quality products to our customers," claims Martin Madaus, chairman & CEO of Millipore. The 110,000 ft2 building contains 47,000 ft2 of lab space, and consolidates multiple functions.

Millipore says that the centre will support the needs of its global customers involved in life science research and the production of biopharmaceutical drugs, with 65% of the centre's revenues coming from outside the USA.

www.millipore.com